Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Clinical trial NCT00343512 · TERMINATED
Trial details
- NCT number
- NCT00343512
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2008-03-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.